Form 4: Eli Lilly Director William G. Kaelin Jr. Acquires Shares

Director William G. Kaelin Jr. acquired shares of Eli Lilly & Co. common stock on November 18, 2024.

Summary

• William G. Kaelin Jr., a director at Eli Lilly & Co., acquired shares of the company's common stock.
• The transaction occurred on November 18, 2024.
• Mr. Kaelin acquired 302.53 shares at a price of $727.2 per share.
• Following the transaction, Mr. Kaelin directly owns 21,464.71 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director purchasing shares is generally seen as a good sign, indicating confidence in the company's future. However, it's a single transaction and not a major event.

Positives

• A director's purchase of company stock can be seen as a positive signal of confidence in the company's future.

Industry Context

Insider trading activity is closely monitored by regulators and investors as it can provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The transaction is typical for directors who may receive stock as part of their compensation or choose to invest in the company.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

insider trading, stock acquisition, director, common stock, Eli Lilly, LLY